ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Glibenclamid Sandoz® 3,5:Sandoz Pharmaceuticals AG
Vollst. FachinformationDDDDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
Reg.InhaberStand d. Info. 
A10BB01 - GlibenclamideATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
 
A10 - Drugs Used in Diabetes
 
A10B - Blood Glucose Lowering Drugs, Excl. Insulins

Fixed combinations of blood glucose lowering drugs and lipid modifying agentes are classified here.

A10BB - Sulfonylureas
 

The DDD for micronized glibenclamide is lower compared to non-micronized formulations, due to higher bioavailability.
The DDD for gliclazide is based on the modified release formulation.

A10BB01 - Glibenclamide
StärkeAdm.RouteNote
 Omicrocryst.substance
 O 
2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home